Cargando…
Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ)()
Bisphosphonate-related osteonecrosis of the jaw (BRONJ), characterized by refractory bone exposure, has recently emerged as a serious side effect of bisphosphonate (BPs) treatment. We discuss novel insights that may help to improve the efficacy of BRONJ treatment and prevention. Our report highlight...
Autores principales: | Kishimoto, Hiromitsu, Noguchi, Kazuma, Takaoka, Kazuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526304/ https://www.ncbi.nlm.nih.gov/pubmed/31193410 http://dx.doi.org/10.1016/j.jdsr.2018.09.002 |
Ejemplares similares
-
Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013) -
Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)
por: Jang, Hyo-Won, et al.
Publicado: (2015) -
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
por: Zushi, Yusuke, et al.
Publicado: (2017) -
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
por: Petcu, Eugen B, et al.
Publicado: (2012)